Identification of mutations of the arginine vasopressin-neurophysm II gene in two kindreds with familial central diabetes insipidus

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 693-696

  Heppner, Christina ^a,b   Kotzka, Jörg ^a   Bullmann, Catharina ^a   Krone, Wilhelm ^a   Müller Wieland, Dirk ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; NEUROPHYSIN;

AGED; AMINO ACID SEQUENCE; AUTOSOMAL INHERITANCE; CHILD; CLINICAL ARTICLE; DIABETES INSIPIDUS; DISEASE PREDISPOSITION; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; INFANT; MISSENSE MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0031765316     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.2.4571     Document Type: Review

References (25)

1. Pendersen EB, Lamm LU, Albertsen K, et al. 1985 Familial cranial diabetes insipidus: a report of five families. Genetic, diagnostic and therapeutic aspects. Q J Med. 57:883-896.
2. Kaplowitz PB, D'Ercole AJ, Robertson GL. 1982 Radioimmunoassay of vasopressin in familial central diabetes insipidus. J Pediatr. 100:76-81.
3. Os I, Aakesson I, Enger E. 1985 Plasma vasopressin in hereditary cranial diabetes insipidus. Acta Med Scand. 217:429-434.
4. Rao VVN, Loffler C, Battey J, Haussmann I. 1992 The human gene for oxytocin-neurophysin 1 (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet Cell Genet. 61:271-273.
5. Sausville E, Carney D, Battey J. 1985 The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem. 260:10236-10241.
6. Rittig S, Robertson GL, Siggard C, et al. 1996 Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet. 58:107-117.
7. Ueta J, Taniguchi S, Yoshida A, et al. 1996 A new type of familial central diabetes insipidus caused by a single base substitution in the neurohypophysin II coding region of the vasopressin gene. J Clin Endocrinol Metab. 81:1787-1790.
8. Rauch F, Lenzner C, Nürnberg P, Frömmel C, Vetter U. 1996 A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf). 44:45-51.
9. Rutishauser, J, Boni-Schnetzler M, Boni J, et al. 1996 A novel point mutation in the translation codon of the pre-pro-vasopressin-neurophysin II gene: co-segregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab. 81:192-198.
10. Rittig S, Siggard C, Ozata M, et al. 1996 Familial neurohypophyseal diabetes insipidus due to mutation that substitutes histidine for tyrosine-2 in the antidiuretic hormone. J Invest Med. 44:387A.
11. Repaske DR, Summar ML, Krishnamani MRS, et al. 1996 Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab. 81:2328-2334.
12. 1 → Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. J Clin Endocrinol Metab. 82:51-56.
13. Ito M, Mori Y, Oiso Y, Saito H. 1941 A single base substitution in the coding region for neurohypophysin II associated with familial central diabetes insipidus. J Clin Invest. 87:725-728.
14. Saiki RK, Gelfand DH, Stoffel S, et al. 1988 Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:487-491.
15. Sanger F, Nicken S, Coulon AR. 1977 DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA. 74:5463-5467.
16. Ito M, Oiso Y, Murase T, et al. 1993 Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause of familial central diabetes insipidus. J Clin Invest. 91:2565-2571.
17. McLeod JF, Kovacs L, Gaskill MB, Rittig S, Bradley GS, Robertson GL. 1993 Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation. J Clin Endocrinol Metab. 77:599A-599G.
18. Chen L, Rose JP, Breslow E, et al. 1991 Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 Å determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom. Proc Natl Acad Sci USA. 88:4240-4244.
19. Ito M, Jameson JL, Ito M. 1997 Molecular basis of autosomal dominant neurophyseal diabetes insipidus. J Clin Invest. 99:1897-1905.
20. Bravennan LE, Mancini JP, McGoldrick DM. 1965 Hereditary idiopathic diabetes insipidus: a case report with autopsy findings. Ann Intern Med. 63:503-508.
21. Bergeron C, Kovacs K, Ezrin C, Mizzen C. 1991 Hereditary diabetes insipidus: an immunohistochemical study of the hypothalamus and the pituitary gland. Acta Neuropathol. 81:345-348.
22. Martin FIR. 1959 Familial diabetes insipidus. Q J Med. 28:573-558.
23. Bahnsen, U Oosting, F Swaab, DF Nahke P, Richter D, Schmale H. 1992 A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. EMBO J. 11:19-23.
24. Baylis PH, Robertson GL. 1981 Vasopressin function in familial cranial diabetes insipidus. Postgrad Med J. 57:36-40.
25. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. 1976 The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 31:155A-163A